对肝细胞癌,特别是中期(BCLC-B期)肝细胞癌(后简称肝癌),肝部分切除或全肝切除肝移植是其明确的可能治愈的手段。虽然肝移植治疗符合选择标准的肝癌,其5年总体生存率和无瘤生存率都比肝部分切除高,但供肝短缺是全世界都存在的巨大问题,大大地限制了肝移植的开展,因此,肝部分切除就成为原发性肝癌可能治愈的常规手段。但是,我国的肝癌多源于慢性乙型肝炎,大约80%的肝癌伴有肝硬化。对伴有肝硬化的肝癌行手术切除, Hepatocellular carcinoma, especially in the intermediate (BCLC-B) stage of hepatocellular carcinoma (hereinafter referred to as liver cancer), partial hepatectomy or total hepatectomy liver transplantation is its clear possible cure. Although liver transplantation meets the selection criteria of liver cancer, its 5-year overall survival and tumor-free survival rates are higher than the partial resection, but the shortage of donor liver is a huge problem in the world, greatly limiting the development of liver transplantation, Therefore, resection of the liver has become the conventional means of treatment of primary liver cancer may be. However, our country’s liver cancer mostly comes from chronic hepatitis B, and about 80% of liver cancer is accompanied by cirrhosis. Surgical resection of liver cancer with cirrhosis,